Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice.

Neuroscience letters2002Xu K, Xu YH, Chen JF, et al.

Study designOther primary literature

SubjectAnimal

Record checks

Study design: Other primary literature
Subject: Animal
Publication year: 2002
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsBinding SitesCaffeineDopamineDopamine AgentsDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsDrug Administration ScheduleDrug ToleranceMaleMazindolMembrane GlycoproteinsMembrane Transport ProteinsMiceMice, Inbred C57BLMotor ActivityNeostriatumNerve Tissue ProteinsNeuronsNeuroprotective AgentsNeurotoxinsParkinsonian DisordersPurinergic P1 Receptor AntagonistsRadioligand AssayReceptor, Adenosine A2AReceptors, Purinergic P1Tritium

DOI 10.1016/s0304-3940(02)00069-1

PMID 11958832

View source →